Results 131 to 140 of about 25,215 (206)

Antibiotic-associated encephalopathy: A retrospective pharmacovigilance study based on 21 years of data from the US FDA Adverse Event Reporting System. [PDF]

Medicine (Baltimore)
Wang H, Jiang H, Yang H, Tang J, Zhang J.   +4 more
europepmc   +1 more source

Side Effects of First-Line Anti-tubercular Therapy (ATT): Does an Alternative Regimen Exist? [PDF]

Cureus
Goswami G, Nirala P, Tandon R, Kalra P, Tariq M, Singh L.   +5 more
europepmc   +1 more source

Beyond Rifampin: Evaluating Rifapentine and Rifabutin as Alternative Treatments for TB Meningitis. [PDF]

J Infect Dis
Chen X, Ruiz-Gonzalez CE, Masias-Leon Y, Singh M, Nino-Meza OJ, Peloquin CA, Artemov D, Jain SK.   +7 more
europepmc   +1 more source

Sigmoid colonic tuberculosis presenting as a colovesical fistula mimicking colorectal malignancy: a case report. [PDF]

Front Med (Lausanne)
Zhong L, Xia K, Fan Y.
europepmc   +1 more source

Innovating shorter, all-oral, precise, individualized treatment regimen for rifampicin-resistant tuberculosis (INSPIRE TB): study protocol for a pragmatic randomised controlled trial. [PDF]

BMC Infect Dis
Zhang Y, Li Y, Ren Y, Li T, Xing Y, Wu J, Ren P, Sun F, Zhang W, INSPIRE TB study group.   +9 more
europepmc   +1 more source

Anti-Tubercular Drug-Induced Liver Injury: Current Understanding and Emerging Directions. [PDF]

JGH Open
Prasad S, Narang H, Kedia S, Ahuja V.
europepmc   +1 more source

Current and emerging therapies for pulmonary tuberculosis in adults. [PDF]

BMJ Med
Mahmood A, Ashfaq MB, Drain C, Melby E, Hunter M, Shaw TD.   +5 more
europepmc   +1 more source

Sertraline Enhances Bacterial Control without Adversely Affecting the Pharmacodynamic-Pharmacokinetic Properties of Frontline Tuberculosis Drugs. [PDF]

ACS Pharmacol Transl Sci
Bisht K, Yadav M, Madan M, Biswas L, Pradhan R, Taliyan R, Singh M, Verma AK, Rao V.   +8 more
europepmc   +1 more source

Curated Cases from the TB Expert Network: Unplugged!: Navigating Uncertainty in Treatment of a Child with Multidrug-Resistant Tuberculosis. [PDF]

J Clin Tuberc Other Mycobact Dis
Gaensbauer J, Harrison E, Wendorf K, Armitige L, Corriveau E, Haley CA, Weld ED, Chen L, Ramesh V, Goswami N.   +9 more
europepmc   +1 more source